Venture Med Group

VentureMed Group (VMG) designs, develops and markets innovative medical devices which enable interventionalists to cost effectively treat peripheral artery diseases and improve the lives of their patients.

Founded by physicians who understand the clinical, medical and financial demands in today’s healthcare environment, VMG creates truly cost effective solutions. Their flagship product, the FLEX Scoring Catheter enables providers to reduce expensive inventory costs while offering the interventionalist more treatment options from a single device.

Venture Med Group headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $2.7B in funding across 96 round(s). With a team of 1-10 employees, Venture Med Group is actively contributing to advancements in Biotechnology. Their latest funding round, Angel Round - Venture Med Group, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.